<p>MICROTECH MED-B (02235.HK) announced its interim results for the six months ending in June, with operating revenue of RMB 246 million, an increase of 63.1% year-on-year; gross profit of RMB 127 million, up 57.7%. The loss narrowed significantly from RMB 37.74 million in the same period last year to RMB 2.29 million, mainly benefiting from the expansion of sales scale and the deepening of comprehensive budget control to enhance operational efficiency; loss per share is 0.5 cents. No dividend is declared</p>

02235

<p>MICROTECH MED-B announced its interim results for the six months ending in June, with operating revenue of RMB 246 million, an increase of 63.1% year-on-year; gross profit of RMB 127 million, up 57.7%. The loss narrowed significantly from RMB 37.74 million in the same period last year to RMB 2.29 million, mainly benefiting from the expansion of sales scale and the deepening of comprehensive budget control to enhance operational efficiency; loss per share is 0.5 cents. No dividend is declared</p>

"Performance" MICROTECH MED's mid-term loss narrowed to 2.29 million RMB